BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23978304)

  • 21. Alterations in macrophage phenotypes in experimental venous thrombosis.
    Gallagher KA; Obi AT; Elfline MA; Hogikyan E; Luke CE; Henke S; Coleman D; Henke PK
    J Vasc Surg Venous Lymphat Disord; 2016 Oct; 4(4):463-71. PubMed ID: 27639001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring.
    Kessinger CW; Kim JW; Henke PK; Thompson B; McCarthy JR; Hara T; Sillesen M; Margey RJ; Libby P; Weissleder R; Lin CP; Jaffer FA
    PLoS One; 2015; 10(2):e0116621. PubMed ID: 25680183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.
    Nosaka M; Ishida Y; Kimura A; Kuninaka Y; Taruya A; Furuta M; Mukaida N; Kondo T
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2638-2650. PubMed ID: 30354252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S; Lee JG; Lovett DH; Sarkar R
    J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
    Kessinger CW; Qi G; Hassan MZO; Henke PK; Tawakol A; Jaffer FA
    Circ Cardiovasc Imaging; 2021 Mar; 14(3):e011898. PubMed ID: 33724049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis.
    DeRoo E; Martinod K; Cherpokova D; Fuchs T; Cifuni S; Chu L; Staudinger C; Wagner DD
    J Thromb Haemost; 2021 Feb; 19(2):387-399. PubMed ID: 33058430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep vein thrombosis resolution is not accelerated with increased neovascularization.
    Varma MR; Moaveni DM; Dewyer NA; Varga AJ; Deatrick KB; Kunkel SL; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2004 Sep; 40(3):536-42. PubMed ID: 15337885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
    Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
    J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner.
    Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2014 Oct; 2(4):441-450.e1. PubMed ID: 25419511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.
    Wang C; Yang F; Xu Z; Shi D; Chen D; Dai J; Gu N; Jiang Q
    Thromb Res; 2013 Jan; 131(1):e31-8. PubMed ID: 23199547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.
    Myers DD; Henke PK; Wrobleski SK; Hawley AE; Farris DM; Chapman AM; Knipp BS; Thanaporn P; Schaub RG; Greenfield LJ; Wakefield TW
    J Vasc Surg; 2002 Nov; 36(5):928-38. PubMed ID: 12422103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of IFN-γ accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice.
    Nosaka M; Ishida Y; Kimura A; Kuninaka Y; Inui M; Mukaida N; Kondo T
    J Clin Invest; 2011 Jul; 121(7):2911-20. PubMed ID: 21646723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.
    Henke PK; Varga A; De S; Deatrick CB; Eliason J; Arenberg DA; Sukheepod P; Thanaporn P; Kunkel SL; Upchurch GR; Wakefield TW
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1130-7. PubMed ID: 15105284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
    Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
    Myers DD; Henke PK; Bedard PW; Wrobleski SK; Kaila N; Shaw G; Meier TR; Hawley AE; Schaub RG; Wakefield TW
    J Vasc Surg; 2006 Sep; 44(3):625-32. PubMed ID: 16950445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postthrombotic vein wall remodeling: preliminary observations.
    Deatrick KB; Elfline M; Baker N; Luke CE; Blackburn S; Stabler C; Wakefield TW; Henke PK
    J Vasc Surg; 2011 Jan; 53(1):139-46. PubMed ID: 20869834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice.
    Bouzeghrane F; Zhang X; Gevry G; Raymond J
    J Vasc Surg; 2008 Dec; 48(6):1575-84. PubMed ID: 18829216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.
    Henke PK; Mitsuya M; Luke CE; Elfline MA; Baldwin JF; Deatrick KB; Diaz JA; Sood V; Upchurch GR; Wakefield TW; Hogaboam C; Kunkel SL
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):43-9. PubMed ID: 20966396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model.
    Henke PK; Pearce CG; Moaveni DM; Moore AJ; Lynch EM; Longo C; Varma M; Dewyer NA; Deatrick KB; Upchurch GR; Wakefield TW; Hogaboam C; Kunkel SL
    J Immunol; 2006 Sep; 177(5):3388-97. PubMed ID: 16920980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role and mechanism of tissue plasminogen activator in venous wall fibrosis remodeling after deep venous thrombosis via the glycogen synthase kinase-3 beta signaling pathway.
    Yin M; Tian S; Huang X; Huang Y; Jiang M
    J Surg Res; 2013 Oct; 184(2):1182-95. PubMed ID: 23632004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.